Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti-Angiogenic Therapy After Autologous Stem Cell Rescue (ASCR) for Pediatric Solid Tumors

NCT01661400 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT01661400
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01661400 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti-Angiogenic Therapy After Autologous Stem Cell Rescue (ASCR) for Pediatric Solid Tumors
Lead sponsor
Washington University School of Medicine
Phase
Phase 1
Overall status
Completed
Start date
October 26, 2012
Completion date
December 27, 2023
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioma, neuroectodermal tumors, primitive, osteosarcoma, retinoblastoma, rhabdomyosarcoma, sarcoma, ewing, wilms tumor